Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4
Authors
Keywords
-
Journal
NATURE
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2017-12-06
DOI
10.1038/nature25016
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice
- (2017) Lindsay A. Becker et al. NATURE
- Proteasome inhibitor-adapted myeloma cells are largely independent from proteasome activity and show complex proteomic changes, in particular in redox and energy metabolism
- (2016) G P Soriano et al. LEUKEMIA
- HSF1: Guardian of Proteostasis in Cancer
- (2016) Chengkai Dai et al. TRENDS IN CELL BIOLOGY
- Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein Homeostasis
- (2015) Daniel J. Anderson et al. CANCER CELL
- Copper improves the anti-angiogenic activity of disulfiram through the EGFR/Src/VEGF pathway in gliomas
- (2015) Yi Li et al. CANCER LETTERS
- Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer
- (2015) Jennifer L. Allensworth et al. Molecular Oncology
- A Phase IIb Trial Assessing the Addition of Disulfiram to Chemotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer
- (2015) H. Nechushtan et al. ONCOLOGIST
- High expression of valosin-containing protein predicts poor prognosis in patients with breast carcinoma
- (2015) Yan Cui et al. TUMOR BIOLOGY
- Liposome encapsulated Disulfiram inhibits NFκB pathway and targets breast cancer stem cells in vitro and in vivo
- (2015) Peng Liu et al. Oncotarget
- Proteotoxic crisis, the ubiquitin-proteasome system, and cancer therapy
- (2014) Raymond J Deshaies BMC BIOLOGY
- Copper Signaling Axis as a Target for Prostate Cancer Therapeutics
- (2014) R. Safi et al. CANCER RESEARCH
- The p97-Ufd1-Npl4 ATPase complex ensures robustness of the G2/M checkpoint by facilitating CDC25A degradation
- (2014) Anne Riemer et al. CELL CYCLE
- Disulfiram targeting lymphoid malignant cell lines via ROS-JNK activation as well as Nrf2 and NF-kB pathway inhibition
- (2014) Jie Zha et al. Journal of Translational Medicine
- A Cellular System that Degrades Misfolded Proteins and Protects against Neurodegeneration
- (2014) Lili Guo et al. MOLECULAR CELL
- p97-dependent retrotranslocation and proteolytic processing govern formation of active Nrf1 upon proteasome inhibition
- (2014) Senthil K Radhakrishnan et al. eLife
- Molecular Chaperone Functions in Protein Folding and Proteostasis
- (2013) Yujin E. Kim et al. Annual Review of Biochemistry
- The p97-UFD1L-NPL4 Protein Complex Mediates Cytokine-Induced I B Proteolysis
- (2013) J.-M. Li et al. MOLECULAR AND CELLULAR BIOLOGY
- Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death
- (2013) Paola Magnaghi et al. Nature Chemical Biology
- Combined Inhibition of p97 and the Proteasome Causes Lethal Disruption of the Secretory Apparatus in Multiple Myeloma Cells
- (2013) Holger W. Auner et al. PLoS One
- Alcohol drinking and all cancer mortality: a meta-analysis
- (2012) M. Jin et al. ANNALS OF ONCOLOGY
- Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system
- (2012) Hemmo Meyer et al. NATURE CELL BIOLOGY
- Disulfiram modulated ROS–MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties
- (2011) N C Yip et al. BRITISH JOURNAL OF CANCER
- Targeting Malignancies with Disulfiram (Antabuse): Multidrug Resistance, Angiogenesis, and Proteasome
- (2011) B. Cvek CURRENT CANCER DRUG TARGETS
- Nonprofit drugs as the salvation of the world's healthcare systems: the case of Antabuse (disulfiram)
- (2011) Boris Cvek DRUG DISCOVERY TODAY
- Quantitative Cell-based Protein Degradation Assays to Identify and Classify Drugs That Target the Ubiquitin-Proteasome System
- (2011) Tsui-Fen Chou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mining for therapeutic gold
- (2011) Francis S. Collins NATURE REVIEWS DRUG DISCOVERY
- Cell death assays for drug discovery
- (2011) Oliver Kepp et al. NATURE REVIEWS DRUG DISCOVERY
- Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways
- (2011) T.-F. Chou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Purification of proteins containing zinc finger domains using immobilized metal ion affinity chromatography
- (2011) Irena Voráčková et al. PROTEIN EXPRESSION AND PURIFICATION
- Introduction to Danish (nationwide) registers on health and social issues: Structure, access, legislation, and archiving
- (2011) Lau Caspar Thygesen et al. SCANDINAVIAN JOURNAL OF PUBLIC HEALTH
- RNF168 Binds and Amplifies Ubiquitin Conjugates on Damaged Chromosomes to Allow Accumulation of Repair Proteins
- (2009) Carsten Doil et al. CELL
- High-Throughput Cell-Based Screening of 4910 Known Drugs and Drug-like Small Molecules Identifies Disulfiram as an Inhibitor of Prostate Cancer Cell Growth
- (2009) K. Iljin et al. CLINICAL CANCER RESEARCH
- Target identification using drug affinity responsive target stability (DARTS)
- (2009) B. Lomenick et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- UBXD7 Binds Multiple Ubiquitin Ligases and Implicates p97 in HIF1α Turnover
- (2008) Gabriela Alexandru et al. CELL
- Analysis of Npl4 deletion mutants in mammalian cells unravels new Ufd1-interacting motifs and suggests a regulatory role of Npl4 in ERAD
- (2008) Agnieszka Lass et al. EXPERIMENTAL CELL RESEARCH
- Ni(II), Cu(II), and Zn(II) Diethyldithiocarbamate Complexes Show Various Activities Against the Proteasome in Breast Cancer Cells
- (2008) Boris Cvek et al. JOURNAL OF MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now